THE NEW SUPER HGH

Key Features of Pfizer NGENLA 60mg Pen:

• Convenience: The NGENLA pen is a disposable, prefilled, and premixed device, simplifying the growth hormone injection process.
• Certified Quality: NGENLA has received certification across multiple European countries and is  top-tier product quality.
• Ease of Use: With NGENLA, there’s no need for reconstitution or loading. The pen is ready to use, providing consistent, effective treatment with once-a-week injections, delivering results comparable to daily HGH treatments.

• How to Calculate NGENLA Dosage ?

  Each NGENLA pen contains 60mg/1.2ml of growth hormone (somatrogon), designed for once-weekly injections, offering a more convenient alternative to daily HGH treatments like Genotropin.

  Here’s how the dosage calculation works:

  • If you’re using 6 IU of Genotropin daily, that totals 42 IU weekly (6 IU x 7 days).
  • With NGENLA, you only need a single weekly injection of 42 IU, which translates to 14mg per week.

  Here’s how the dosage translates if you’re switching from daily Genotropin to weekly NGENLA:

  • 2 IU daily = 14 IU weekly = 5mg of NGENLA per week
  • 4 IU daily = 28 IU weekly = 9mg of NGENLA per week
  • 6 IU daily = 42 IU weekly = 14mg of NGENLA per week
  • 8 IU daily = 56 IU weekly = 18mg of NGENLA per week
  • 10 IU daily = 70 IU weekly = 24mg of NGENLA per week

  Quick Reference for NGENLA Dosing:

  • 14 IU weekly = 5mg of NGENLA
  • 28 IU weekly = 9mg of NGENLA
  • 42 IU weekly = 14mg of NGENLA
  • 56 IU weekly = 18mg of NGENLA
  • 70 IU weekly = 24mg of NGENLA

  With NGENLA, you only need one weekly injection to maintain your growth hormone therapy, simplifying your routine without sacrificing any benefits.

• What is Somatrogon?

  Somatrogon is a long-acting human growth hormone (HGH) analogue developed by Pfizer and OPKO Health. It is used to treat growth hormone deficiencies by stimulating growth in children and potentially adults who have inadequate levels of natural growth hormone.

  Somatrogon is structurally similar to somatropin (the standard recombinant human growth hormone), but it has been modified to have a longer half-life in the body. This modification allows for less frequent dosing—typically once a week—compared to the daily injections required with traditional growth hormone therapies like somatropin.

  The longer action of Somatrogon is achieved by attaching a portion of a protein called the human chorionic gonadotropin (hCG) to the growth hormone molecule. This addition slows down the rate at which the hormone is cleared from the bloodstream, thus extending its duration of action.

  Somatrogon offers similar benefits to traditional growth hormone therapy, including promoting growth in height, improving muscle mass, reducing body fat, and supporting overall development in children with growth hormone deficiency. It is administered via a subcutaneous injection, typically once a week.